Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX)
CUSIP: 501976104
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.00001 per share
- Shares outstanding
- 56,833,213
- Total 13F shares
- 22,688,863
- Share change
- -540,862
- Total reported value
- $136,134,153
- Price per share
- $6.00
- Number of holders
- 74
- Value change
- -$2,158,017
- Number of buys
- 27
- Number of sells
- 42
Quarterly Holders Quick Answers
What is CUSIP 501976104?
CUSIP 501976104 identifies KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 501976104:
Top shareholders of KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vida Ventures Advisors, LLC |
13F
|
Company |
8%
|
4,523,924
|
$13,888,447 | — | 30 Jun 2025 | |
| GILEAD SCIENCES, INC. |
13F
3/4/5
|
Company · 10%+ Owner |
7.3%
|
4,126,119
|
$12,667,185 | — | 30 Jun 2025 | |
| Bain Capital Life Sciences Investors, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
5.9%
|
3,368,370
|
$10,340,896 | — | 30 Jun 2025 | |
| Fred E. Cohen |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
4,605,909
mixed-class rows
|
$9,580,576 | — | 29 May 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.2%
|
1,830,501
|
$5,621,000 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.3%
|
1,312,767
|
$4,030,195 | — | 30 Jun 2025 | |
| Insight Holdings Group, LLC |
13F
|
Company |
1.7%
|
989,054
|
$3,036,396 | — | 30 Jun 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.2%
|
695,027
|
$2,133,733 | — | 30 Jun 2025 | |
| MBB PUBLIC MARKETS I LLC |
13F
|
Company |
1.1%
|
614,477
|
$1,886,444 | — | 30 Jun 2025 | |
| Catalio Capital Management, LP |
13F
|
Company |
1%
|
586,909
|
$1,801,811 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.94%
|
533,467
|
$1,637,745 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.8%
|
452,560
|
$1,389,359 | — | 30 Jun 2025 | |
| Kera Capital Partners, Inc. |
13F
|
Company |
0.74%
|
421,924
|
$1,295,307 | — | 30 Jun 2025 | |
| Peapod Lane Capital LLC |
13F
|
Company |
0.7%
|
396,763
|
$1,218,092 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.57%
|
325,389
|
$998,944 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
287,601
|
$883,111 | — | 30 Jun 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.44%
|
252,196
|
$774,242 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.36%
|
202,038
|
$620,257 | — | 30 Jun 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.25%
|
144,623
|
$443,993 | — | 30 Jun 2025 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.25%
|
142,542
|
$437,604 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.24%
|
136,378
|
$418,680 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.22%
|
122,417
|
$375,820 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.21%
|
120,584
|
$370,193 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.21%
|
118,606
|
$364,120 | — | 30 Jun 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.21%
|
118,297
|
$363,172 | — | 30 Jun 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.18%
|
100,158
|
$307,485 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.17%
|
98,158
|
$301,345 | — | 30 Jun 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.17%
|
94,300
|
$289,501 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.16%
|
91,300
|
$280,291 | — | 30 Jun 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.15%
|
87,769
|
$269,451 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.13%
|
72,269
|
$221,866 | — | 30 Jun 2025 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.01%
|
7,500
|
$196,000 | — | 30 Jun 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
62,900
|
$193,103 | — | 30 Jun 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.11%
|
62,057
|
$190,515 | — | 30 Jun 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.1%
|
55,522
|
$170,453 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.09%
|
51,678
|
$158,651 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.09%
|
50,394
|
$154,710 | — | 30 Jun 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.08%
|
44,000
|
$135,080 | — | 30 Jun 2025 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.07%
|
42,025
|
$129,017 | — | 30 Jun 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.07%
|
38,965
|
$119,622 | — | 30 Jun 2025 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
36,247
|
$111,278 | — | 30 Jun 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.06%
|
34,939
|
$107,263 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
33,756
|
$103,630 | — | 30 Jun 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.05%
|
29,730
|
$91,271 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.05%
|
27,855
|
$85,514 | — | 30 Jun 2025 | |
| Jain Global LLC |
13F
|
Company |
0.05%
|
26,243
|
$80,566 | — | 30 Jun 2025 | |
| CAXTON CORP |
13F
|
Company |
0.04%
|
22,981
|
$70,552 | — | 30 Jun 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.04%
|
20,171
|
$61,000 | — | 30 Jun 2025 | |
| Vanguard Personalized Indexing Management, LLC |
13F
|
Company |
0.03%
|
19,122
|
$58,705 | — | 30 Jun 2025 | |
| Ethic Inc. |
13F
|
Company |
0.03%
|
17,036
|
$55,878 | — | 30 Jun 2025 |
Institutional Holders of Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX) as of Q3 2025
As of 30 Sep 2025,
Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,688,863 shares.
The largest 10 holders included
Vida Ventures Advisors, LLC, GILEAD SCIENCES, INC., Bain Capital Life Sciences Investors, LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Insight Holdings Group, LLC, FRANKLIN RESOURCES INC, MBB PUBLIC MARKETS I LLC, Catalio Capital Management, LP, and MILLENNIUM MANAGEMENT LLC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
77
Q3 2025 holders
74
Holder diff
-3
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.